Biological markers of sepsis-Reference-Cited by-同舟云学术

Biological markers of sepsis

Published:2023 Issue:1 Volume:10 Page:
ISSN:2500-2236
Container-title:Microbiology Independent Research Journal (MIR Journal)
language:en
Short-container-title:

Author:

Radygina Lubov V.¹^ORCID,Mochalova Larisa V.¹^ORCID

Affiliation:

1. All-Russian Institute for Scientific and Technical Information of the Russian Academy of Sciences (VINITI RAS), 20 Usievich St., Moscow, 125315 Russia

Abstract

ABSTRACT Currently, the issues of early sepsis diagnosis, assessment of the effectiveness of therapies conducted, and disease prognosis are extremely relevant. In the case of sepsis, timely medical assistance is complicated by the ambiguity of symptoms and the absence of a specific diagnostic test. Therefore, the search for sepsis biomarkers with diagnostic, prognostic, and therapeutic potential is underway in medical centers worldwide. This review summarizes research results regarding the diagnostic values of sepsis biomarkers – their sensitivity, specificity, and prognostic value – as presented in scientific publications indexed in international databases.

Publisher

Doctrine

Link

https://scienceopen.com/document_file/7e240a82-36d1-4aa6-86f7-272c267857f0/ScienceOpen/638e318f-646f-4927-b779-2f999ac783fd.pdf

Reference113 articles.

1. Gavrilov AV. Sepsis. Study guide. Blagoveshchensk, 2015, 63 pp. (In Russian). https://www.amursma.ru/upload/iblock/141/Sepsis.pdf.

2. Casalboni S, Valli G, Terlizzi F, Mastracchi M, Fidelio G, De Marco F et al. 30 Days Mortality Prognostic Value of POCT Bio-Adrenomedullin and Proenkephalin in Patients with Sepsis in the Emergency Department. Medicina (Kaunas) 2022; 58(12), 1786. 10.3390/medicina58121786.

3. Méndez Hernández R, Ramasco Rueda F. Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence. J Pers Med 2023; 13(2), 333. 10.3390/jpm13020333.

4. Póvoa P, Coelho L, Dal-Pizzol F, Ferrer R, Huttner A, Conway Morris A et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med 2023; 49(2), 142-53. 10.1007/s00134-022-06956-y.

5. Tsangaris I, Antonakos N, Fantoni M, Kaplanski G, Kyriazopoulou E, Veas F, Clemens M. Biomarkers: can they really guide our daily practice? Shock 2023; 59 (3S Suppl 1), 16-20. 10.1097/SHK.0000000000001957.